Ionis Pharmaceuticals Inc IONS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/27/23 EST
40.02UNCH (UNCH)
Volume
4,696
Close
40.02quote price arrow up+0.64 (+1.63%)
Volume
482,461
52 week range
28.25 - 48.82
Loading...
  • Open39.43
  • Day High40.20
  • Day Low39.15
  • Prev Close39.38
  • 52 Week High48.82
  • 52 Week High Date09/12/22
  • 52 Week Low28.25
  • 52 Week Low Date01/31/22

Key Stats

  • Market Cap5.685B
  • Shares Out142.05M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.54
  • YTD % Change5.96

KEY STATS

  • Open39.43
  • Day High40.20
  • Day Low39.15
  • Prev Close39.38
  • 52 Week High48.82
  • 52 Week High Date09/12/22
  • 52 Week Low28.25
  • 52 Week Low Date01/31/22
  • Market Cap5.685B
  • Shares Out142.05M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.54
  • YTD % Change5.96

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)691.19
  • Fwd P/E (NTM)-12.78
  • EBITDA (TTM)35.973M
  • ROE (TTM)1.30%
  • Revenue (TTM)875.483M
  • Gross Margin (TTM)98.55%
  • Net Margin (TTM)0.84%
  • Debt To Equity (MRQ)211.06%

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ionis Pharmaceuticals Inc

 

Profile

MORE
Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on our cardiovascular and neurology franchises. Its products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients of all ages with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. TEGSEDI is for the treatment of patients with polyneuropathy caused by...
Joseph Loscalzo M.D., Ph.D.
Independent Chairman of the Board
Brett Monia Ph.D.
Chief Executive Officer, Director
Elizabeth Hougen
Chief Financial Officer, Executive Vice President - Finance
Eric Swayze Ph.D.
Executive Vice President - Research
Eugene Schneider M.D.
Executive Vice President, Chief Clinical development Officer
Patrick O'Neil Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Address
2855 Gazelle Court
Carlsbad, CA
92010
United States

Top Peers

SYMBOLLASTCHG%CHG
PBH
Prestige Consumer Healthcare Inc
65.69+0.07+0.11%
HRMY
Harmony Biosciences Holdings Inc
48.57-0.25-0.51%
SUPN
Supernus Pharmaceuticals Inc
40.68-0.38-0.93%
CORT
Corcept Therapeutics Inc
23.26+0.32+1.39%
BPMC
Blueprint Medicines Corp
47.78+0.03+0.06%